|
1
|
Zhao J and Jiang GQ: miR-4282 inhibits
proliferation, invasion and metastasis of human breast cancer by
targeting Myc. Eur Rev Med Pharmacol Sci. 22:8763–8771.
2018.PubMed/NCBI
|
|
2
|
McAnena PF, McGuire A, Ramli A, Curran C,
Malone C, McLaughlin R, Barry K, Brown JAL and Kerin MJ: Breast
cancer subtype discordance: Impact on post-recurrence survival and
potential treatment options. BMC Cancer. 18:2032018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mitra S and Dash R: Natural products for
the management and prevention of breast cancer. Evid Based
Complement Alternat Med. 2018:83246962018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Xu H, Guo S, Li W and Yu P: The circular
RNA Cdr1as, via miR-7 and its targets, regulates insulin
transcription and secretion in islet cells. Sci Rep. 5:124532015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nigro JM, Cho KR, Fearon ER, Kern SE,
Ruppert JM, Oliner JD, Kinzler KW and Vogelstein B: Scrambled
exons. Cell. 64:607–613. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang M and Du X: Noncoding RNAs in
gastric cancer: Research progress and prospects. World J
Gastroenterol. 22:6610–6618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang HD, Jiang LH, Sun DW, Hou JC and Ji
ZL: circRNA: A novel type of biomarker for cancer. Breast Cancer.
25:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu W, Tan C, He Y, Zhang G, Xu Y and Tang
J: Functional miRNAs in breast cancer drug resistance. OncoTargets
Ther. 11:1529–1541. 2018. View Article : Google Scholar
|
|
9
|
Yin WB, Yan MG, Fang X, Guo JJ, Xiong W
and Zhang RP: Circulating circular RNA hsa_circ_0001785 acts as a
diagnostic biomarker for breast cancer detection. Clin Chim Acta.
487:363–368. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang Y, Mo Y, Gong Z, Yang X, Yang M,
Zhang S, Xiong F, Xiang B, Zhou M, Liao Q, et al: Circular RNAs in
human cancer. Mol Cancer. 16:252017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang N, Gu Y, Li L, Wang F, Lv P, Xiong Y
and Qiu X: Circular RNA circMYO9B facilitates breast cancer cell
proliferation and invasiveness via upregulating FOXP4 expression by
sponging miR-4316. Arch Biochem Biophys. 653:63–70. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang X and Xie X, Wang H, Xiao X, Yang L,
Tian Z, Guo X, Zhang L, Tang H and Xie X: PDL1 and LDHA act as
ceRNAs in triple negative breast cancer by regulating miR-34a. J
Exp Clin Cancer Res. 36:1292017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
He R, Liu P, Xie X, Zhou Y, Liao Q, Xiong
W, Li X, Li G, Zeng Z and Tang H: circGFRA1 and GFRA1 act as ceRNAs
in triple negative breast cancer by regulating miR-34a. J Exp Clin
Cancer Res. 36:1452017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liang HF, Zhang XZ, Liu BG, Jia GT and Li
WL: Circular RNA circ-ABCB10 promotes breast cancer proliferation
and progression through sponging miR-1271. Am J Cancer Res.
7:1566–1576. 2017.PubMed/NCBI
|
|
15
|
Lü L, Sun J, Shi P, Kong W, Xu K, He B,
Zhang S and Wang J: Identification of circular RNAs as a promising
new class of diagnostic biomarkers for human breast cancer.
Oncotarget. 8:44096–44107. 2017.PubMed/NCBI
|
|
16
|
Wang H, Xiao Y, Wu L and Ma D:
Comprehensive circular RNA profiling reveals the regulatory role of
the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J
Oncol. 52:743–754. 2018.PubMed/NCBI
|
